MARKET

RGTLF

RGTLF

Argent BioPharma
OTCPK
0.150
NaN%
Closed 09:30 05/23 EDT
OPEN
--
PREV CLOSE
0.150
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.429
52 WEEK LOW
0.025
MARKET CAP
10.83M
P/E (TTM)
-0.5423
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RGTLF last week (0512-0516)?
Weekly Report · 5d ago
Weekly Report: what happened at RGTLF last week (0505-0509)?
Weekly Report · 05/12 11:53
Weekly Report: what happened at RGTLF last week (0428-0502)?
Weekly Report · 05/05 11:56
Argent Biopharma Announces Cessation of Securities
TipRanks · 05/02 07:27
Argent BioPharma Reports Strategic Operational Updates and Promising Clinical Trial Results
TipRanks · 04/30 04:07
Weekly Report: what happened at RGTLF last week (0421-0425)?
Weekly Report · 04/28 12:08
Argent BioPharma Issues 2.5 Million New Shares Under Regulatory Exemption
TipRanks · 04/24 02:27
Argent Biopharma Expands Capital with New Share Issuance
TipRanks · 04/24 02:27
More
About RGTLF
Argent BioPharma Ltd, formerly MGC Pharmaceuticals Ltd, is an Australia-based drug discovery company. The Company is focused on developing and supplying accessible and ethically produced plant-derived medicines, combining in-house research with technologies. Its approach combines in-house research with technology, all discovering and producing treatments for unmet medical conditions. Its investigational medicinal (IMPs) products include CannEpil, CimetrA and CogniCann. CimetrA is a phyto medicine based on natural ingredients from Curcumin and Boswellia serrata, delivered in the nanoparticle delivery system, which is being developed for acute lung injury and acute respiratory distress syndrome (ARDS). CannEpil is a phyto medicine based on phytocannabinoid is being developed for the treatment of refractory epilepsy and cerebral palsy. CogniCann is a phyto medicine based on phytocannabinoids is in investigation stage as a treatment for the symptoms associated with dementia and Alzheimer.

Webull offers Argent BioPharma Ltd stock information, including OTCPK: RGTLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGTLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGTLF stock methods without spending real money on the virtual paper trading platform.